Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more

Four line up for drugs research development


FOUR firms are competing for a £20 million pharmaceutical facility in Surrey.

Amec, Bovis Lend Lease, Laing O'Rourke and Skanska are on the shortlist for a new research facility at the Surrey site of US pharmaceuticals firm Eli Lilly. The new 6,000 sq m building is the second phase of the development at Windlesham, the company's research and development base.

Amec already provides a facilities management and property maintenance service at Eli Lilly's three sites in southern England.

Tenders are due to be returned by June 10. Construction is scheduled to start on August 1 with work expected to take around two years.